Protara Therapeutics Inc.
TARA | NASDAQ
$3.62
+$0.11 (+3.13%)
Sep 22, 2026, 12:07 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -3.98 | -2.43 | -0.53 | -0.46 | -1.61 | -5.15 |
PEG Ratio | 0.10 | 0.06 | 0.01 | -0.01 | 0.15 | -0.17 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.16 | 0.65 | 0.31 | 0.30 | 0.47 | 0.88 |
P/FCF Ratio | -4.04 | -3.03 | -0.57 | -1.14 | -2.16 | -7.21 |
P/OCF Ratio | -4.05 | -3.04 | -0.57 | -1.14 | -2.20 | -7.48 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.02 | 0.03 | 0.08 | 0.06 | 0.04 | 0.01 |
Quick Ratio | 14.58 | 15.71 | 11.17 | 14.81 | 21.66 | 58.13 |
Current Ratio | 14.58 | 15.71 | 11.17 | 15.01 | 21.66 | 58.13 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | -58.98 | -27.34 | -1.01K |
Return on Equity | -29.24% | -26.68% | -59.16% | -64.61% | -29.18% | -17.05% |
Return on Assets | -27.42% | -24.58% | -51.19% | -58.22% | -27.38% | -16.73% |
Return on Invested Capital | -32.31% | -28.64% | -59.11% | -61.83% | -28.07% | -17.19% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove TARA